James R. Empfield, EVP, Drug Discovery at Xenon Pharmaceuticals Inc. (XENE), sold 100,868 shares at $38.68 ($3.9M) on 2022-08-12, disclosed to the SEC on 2022-08-16.
Open-market sale of $3.9M XENE by EVP, Drug Discovery. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.02 | 7,257 | $276K | 7.2% |
| 2 | $38.08 | 35,868 | $1.4M | 35.4% |
| 3 | $38.08 | 35,868 | $1.4M | 35.4% |
| 4 | $38.68 | 21,875 | $846K | 22.0% |
| Total | $38.21 avg | 100,868 | $3.9M | 100% |
| Filing → |